J Epidemiol Community Health 2000;54:79–80
Treatment with ivermectin: what works in onecommunity may not work in another
O E Onwujekwe, E N Shu, C C Ndum, P O Okonkwo
Nigeria is highly endemic for onchocerciasis,
Study design
and seven million people are infected, 40
million at risk of infection and 0.2 million blind
study sites with an estimated total population
from the disease.1 Disease control is through
size of 125 000. Interviewer administered
mass distribution of ivermectin (Mectizan) “ a
structured questionnaires were used to inter-
drug that has revolutionized the treatment of
onchocerciasis and other nematode diseases of
selected household heads. Based on a table for
man”.2 What is needed therefore, is to put in
sample sizes,4 404, 393 and 214 household
place an eVective system of drug delivery and
distribution that can be sustained by the
endemic countries themselves.3 An approachfor ivermectin distribution is through commu-
Results and Discussion
nity self treatment, where the communities
Men formed the majority of respondents in the
themselves are actively involved in planning,
three communities, and most respondents were
designing and executing the ivermectin deliv-
between 41 to 60 years in Achi and Nike com-munities, and 20 to 40 years in Toro commu-
ery system. This has been termed community
nity. Table 1 illustrates the community diVer-
directed treatment with ivermectin (CDTI) by
ences of who should distribute ivermectin;
while community based distributors (CBDs)
Control, APOC. CDTI schemes are currently
from super family units were mostly preferred
being tested in Africa to decide on the best
approach. However, the danger lies in extrapo-
workers were preferred in Achi (36%). How-
lating results generated from some communi-
ever, in aggregate terms, CBDs in various
ties to all onchocerciasis endemic communi-
forms were preferred in the three communites.
This result diVers from another study where
characteristics and priorities, and what works
only 26 of 97 villages treated with ivermectin
in one community may not work in another.
preferred community based distribution to the
Therefore, the preferences of individual com-
“mobile” method by external agencies.5 Other
munities must be a priori determined, and the
results showed that: (1) fee for service was the
results used to model and implement appropri-
preferred payment mechanism in Achi (56%)
and Nike (69%), while it was pre-payment in
schemes. This pilot study investigated the pref-
Toro (38%); (2) the three communities wanted
the payments for the ivermectin delivery to be
distributing ivermectin in three Nigerian com-
collected and managed by the community but
munities. This study should be of help to
with the government supervising (Nike, 51%;
Toro, 66%; and Achi, 56%); (3) in Achi, the
establishing sustainable community based and
majority preferred the government to fix the
controlled systems for endemic disease(s)
fees (47%), while in Nike it was the town union
(29%), and in Toro it was a combination of the
Preference of household heads for the diVerent channels for local ivermectin distribution
Through CBDs to be selected from each extended family unit (umunna)
Health Policy Research Unit,
Through CBDs selected from all religious groups
Department of
Through CBDs selected from age grades and schools
Pharmacology and Therapeutics, College of Medicine,
Through a centrally located shop to be managed by nominated community members
Option number 7 but with the shop managed by an external person
University of Nigeria,
Through government health centers and hospitals. PMB 01129 Enugu,
1 A super family unit refers to a group of extended family units that have a common ancestor. Among the Ibos of south eastern
Nigeria where Achi and Nike are in, these are called the “umunna”. 2 A group of super family units comprise a village.
3 The term government workers is used loosely to imply all mobile health workers who go to the communities to distribute ivermec-
tin. They could be from the government or from non-governmental organisations.
town union and the traditional ruling council
in this paper will aid discussions about the
(46%). The possible conclusion is that each
most eVective and sustainable form of CDTI.
community has its unique characteristics andpreferences, and these must be determined
We are grateful to the anonymous referee who provided very
before CDTI is designed and implemented. No
two communities are the same, and what works
Funding: this study received financial support from the UNDP/
in one community may fail in another. It is
World Bank/WHO Special Programme for Research and Train-
ing in Tropical diseases. Conflicts of interest: none.
know their communities very well before start-ing any programme, and a national CDTI
1 Edungbola LD. Onchocerciasis control in Nigeria. Parasitol
policy must make provisions for the use of
Today 1991;7:97–9.
2 Jenkins DC. Ivermectin in the treatment of filariasis and
other nematode diseases of man. Trop Dis Bull 1990;87:R1–
that before using the results of surveys to
embark on community action, in depth analysis
3 Amazigo U, Noma M, Boatin BA, et al. Delivery systems
and cost-recovery in Mectizan treatment for onchocercia-
sis. Ann Trop Med Parasitol 1998;92:S23.
general village assemblies, should be done so
4 Eddy KG. Sampling method and sampling size. WHO/IMR
Regional in-service course on research design and method-
that all areas of conflicts and vagueness about
the scheme would be resolved. These will help
5 Biritwum RBI, Scylla M, Diarra T, et al. Evaluation of iver-
mectin distribution in Benin, Cote d’Ivoire, Ghana and
agenda in designing and implementing CDTI.
Togo: estimation of coverage of treatment and operationalaspects of the distribution system. Ann Trop Med Parasitol
The result of the questionnaire survey reported
1997;91:297–305.
Curriculum Vitae Seyed Ebrahim Eskandari MSc Researcher, Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, 79 Taleghani Avenue, Tehran 14166, Iran Phone: (98-21) 897 0657 Fax phone: (98-21) 897 0658 Email: seyed7049@yahoo.com I. PERSONAL Name : Seyed Ebrahim Last Name : Eskandari Date and Place of
2ND YEAR RESEARCH ELECTIVE RESIDENT’S JOURNAL Randomized, Placebo-Controlled, Double Blinded Clinical Trial of Bupropion (*Wellbutrin) vs. Venlafaxine (*Effexor) for the Treatment of Hot Flashes in Men undergoing Androgen Ablation Therapy for Prostate Cancer Andrew B. Brown A. Study Purpose and Rationale Hot Flashes pose a significant clinical problem worldwide in men who are